Alayde V. Wanderley - Publications

Pharmacogenomic diversity in Amazonian Indigenous populations: implications for Berlin-Frankfurt-Münster acute lymphoblastic leukemia therapy.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: September 22, 2025

Effect of American genomic ancestry on severe toxicities in children with acute lymphoblastic leukemia in the Amazon region.

Journal: Discover oncology

Published: September 30, 2023

Influence of Genetic Variations in miRNA and Genes Encoding Proteins in the miRNA Synthesis Complex on Toxicity of the Treatment of Pediatric B-Cell ALL in the Brazilian Amazon.

Journal: International journal of molecular sciences

Published: November 10, 2022

Re: Market access to new anticancer medicines for children and adolescents with cancer in Europe.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 16, 2022

Identification of Genomic Variants Associated with the Risk of Acute Lymphoblastic Leukemia in Native Americans from Brazilian Amazonia.

Journal: Journal of personalized medicine

Published: March 18, 2022

The Role of SLC22A1 and Genomic Ancestry on Toxicity during Treatment in Children with Acute Lymphoblastic Leukemia of the Amazon Region.

Journal: Genes

Published: December 22, 2021

Correlation of Genetic Variants and the Incidence, Prevalence and Mortality Rates of Acute Lymphoblastic Leukemia.

Journal: Journal of personalized medicine

Published: December 07, 2021

Telomerase (hTERT) Overexpression Reveals a Promising Prognostic Biomarker and Therapeutical Target in Different Clinical Subtypes of Pediatric Acute Lymphoblastic Leukaemia.

Journal: Genes

Published: September 16, 2021

Influence of variants of the drosha, mir499a, and mir938 genes on susceptibility to acute lymphoblastic leukemia in an admixed population from the brazilian amazon.

Journal: American journal of translational research

Published: August 28, 2020

Characterization of pharmacogenetic markers related to Acute Lymphoblastic Leukemia toxicity in Amazonian native Americans population.

Journal: Scientific reports

Published: March 17, 2020

Targeting aurora kinases as a potential prognostic and therapeutical biomarkers in pediatric acute lymphoblastic leukaemia.

Journal: Scientific reports

Published: February 14, 2020

Identifying novel genetic alterations in pediatric acute lymphoblastic leukemia based on copy number analysis.

Journal: Molecular cytogenetics

Published: January 16, 2020